| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | 30-Jun-07 | | Total Revenue |
-
|
-
| 571 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
| 571 | | | Operating Expenses | | Research Development | 195 | 684 | 872 | | Selling General and Administrative | 1,610 | 3,026 | 4,783 | | Non Recurring |
-
|
-
| 1,029 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,805) | (3,710) | (6,113) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (262) | 1,101 | 2,380 | | Earnings Before Interest And Taxes | (2,067) | (2,609) | (3,733) | | Interest Expense | 190 | 2,235 |
-
| | Income Before Tax | (2,257) | (4,844) | (3,733) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,257) | (4,844) | (3,733) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,257) | (4,844) | (3,733) | | Preferred Stock And Other Adjustments | (275) |
-
|
-
| | | Net Income Applicable To Common Shares | ($2,532) | ($4,844) | ($3,733) |
|
0.02% Nasdaq 
0.33%
Income Statement
